|
Former Baxter-BD Trays will now be offered exclusively through BD
Contact: Michael Marinello BD Public Relations (201) 847-7437 Franklin Lakes (January 30, 2006) -- BD Medical, a segment of BD (Becton, Dickinson, and Company), announced that, effective immediately, BD will assume responsibility for the regional anesthesia procedure tray business which was previously run as part of an alliance between BD and Baxter. BD Medical is a leading worldwide supplier of spinal needles and regional anesthesia procedure products. Under the new tray agreement with Baxter, BD now has the exclusive right to market and sell the trays. Baxter will continue to assemble the trays for BD. The agreement will allow customers to take full advantage of BD marketing, sales and customer services, providing greater access to a wider variety of BD products tailored to the anesthesia market. These products represent some of the most advanced and clinically preferred technologies available today. BD anesthesia products are designed to support spinal, epidural, combined spinal and epidural, peripheral block and pain management procedures. BD also offers anesthesia customers leading industry brands for hypodermic needles, syringes and IV catheters. “As the new single-source for trays, customers who are used to ordering Baxter-BD trays can be assured of the same high quality product that the dual company relationship originally provided,” stated Michael Ferrara, Anesthesia Business Director, BD Medical - Medical Surgical Systems. “A seamless transition remains a top customer priority. We expect full integration of the tray product line to be completed by the end of 2006.” For more information, please call 1-888-237-2762. About BD BD, a leading global medical technology company that makes and sells medical devices, instrumented systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs more than 25,000 people in approximately 50 countries throughout the world.The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit www.bd.com.
|